Veracyte

What is Veracyte?

Veracyte is a public genomic-diagnostics company (Nasdaq: VCYT) that combines genomic sequencing with artificial intelligence and machine learning to develop and run diagnostic tests for cancer. Its tests help physicians make clearer treatment decisions across several cancers: Afirma for thyroid nodules, Decipher for prostate (and bladder) cancer risk, Percepta and Envisia for lung conditions, and Prosigna for breast cancer, among others. The clinical value is in reducing uncertainty, for example helping avoid unnecessary surgeries by better classifying whether a nodule is benign or malignant. Veracyte was founded in 2008 and is headquartered in South San Francisco, California, and it went public on Nasdaq in 2013. The company employs roughly 700 people and has grown testing revenue at more than 20% year over year, with total revenue running well over $500M on an annualized basis. Marc Stapley has been CEO since June 2021, having previously been Chief Financial Officer and Chief Administrative Officer at Illumina; the company has announced a CEO succession plan. Because Veracyte both develops the science and runs the tests in its own CLIA labs, its roles split between hands-on laboratory work, field-based commercial roles, corporate functions, and a meaningful set of remote-eligible technical roles.

Mission & values

Transform cancer care for patients worldwide by combining genomic science with AI to give physicians the clear, actionable answers they need to guide treatment.

Qualifications

Veracyte hires across several distinct groups, and remote eligibility depends heavily on which. (1) Laboratory and operations: medical laboratory scientists, lab technicians, genomic and molecular lab staff, and lab operations. These are on-site at the CLIA labs (South San Francisco and other lab locations) and cannot be remote, and clinical lab roles typically require relevant licensure or certification. (2) Technical and R&D roles that are often remote-eligible: bioinformatics, computational biology, data science and machine learning, software and platform engineering, and biostatistics. (3) Commercial and field roles: sales, account management, and medical science liaisons, which are territory-based and field-remote with travel to clinicians. (4) Corporate: regulatory, quality, clinical affairs, medical affairs, finance, legal, marketing, and people, a mix of hybrid and remote. Application flow lives at veracyte.com/company/careers. Because Veracyte handles protected health information and regulated diagnostics, HIPAA, quality-system, and regulatory awareness are valued, and background checks are standard.

Leadership

Hiring process

1. 1

   Apply at veracyte.com/company/careers

   Browse laboratory, bioinformatics/software, commercial/field, and corporate roles and submit through the Veracyte careers site.

2. 2

   Recruiter screen

   Confirms role fit, level, on-site vs remote/field eligibility, licensure (for lab/clinical roles), and salary expectations.

   About 10 days

3. 3

   Hiring manager interview

   Role-specific conversation with the manager who owns the position and the scientific or commercial context.

   About 10 days

4. 4

   Technical or panel interview

   Bioinformatics/ML/software: coding and methods discussion. Lab: technical and quality scenarios. Commercial: case or field role-play.

   About 14 days

5. 5

   Offer and background check

   Offer with base, bonus, and RSUs, followed by the background check and credential verification standard for a regulated diagnostics company.

   About 14 days

Funding

Awards & recognition

• IPO on Nasdaq as VCYT · 2013

  Veracyte

• Testing revenue growing 20%+ year over year · 2026

  Veracyte

Company information

• Industry: Genomic Diagnostics / HealthTech / Oncology
• Location: South San Francisco, CA, USA (lab, office, field, and some remote roles)
• Founded: 2008
• Employees: 700
• Website: www.veracyte.com ↗
• LinkedIn: Company page ↗
• X / Twitter: Profile ↗

Frequently asked questions